Page 149 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 149
PET improves DLBCL response predictors
Supplemental Figure 2. Kaplan-Meier curves for I-PET4 with numbers at risk for progression-free survival in months stratified by DS1-4 vs DS5 result.
Supplemental Figure 3. Kaplan-Meier curves for progression-free survival in months stratified by combined aaIPI and ∆SUVmax subgroups.
147
6a
